The Crick laboratory focuses on the study of the regulation of the immune response during immune challenge and infection of the lung and gut, with a major focus on immune effector molecules called cytokines and their downstream pathways.
Laboratory Scientist (Immunology/ Bacteriology)
27 April 2021, 5:00pm to 5:00pm
Play a key role in an internationally recognised team contributing to global TB vaccine and drug initiatives.
Latest Vaccine Progress in the Field
19 November 2025, 3:00pm to 3:00pm
Prof Rajko Reljic and Dr Camila I de Oliveira presented advances in vaccine development for Buruli ulcer and cutaneous leishmaniasis.
Leiden University Medical Center
Netherlands
Leipzig University
Germany
Leishmaniasis
Leishmaniasis is a group of diseases caused by single-celled Leishmania parasites. It affects an estimated 12 million people worldwide, with 700,000 to one million new cases each year.
Leishmaniasis in the Balkans
4 December 2024, 3:00pm to 3:00pm
Leishmaniasis, once believed to be limited to the Mediterranean region, has now been found throughout the Balkans, including non-Mediterranean countries, and this seminar explored its spread and impact.
Leprosy
Leprosy is a chronic neglected disease caused by the bacterium Mycobacterium leprae. There are an estimated 120,000 new cases of leprosy are diagnosed every year.
LepVax: Advancing Science, Building Partnerships, and Transforming Leprosy Control
Lessons learned in BP vs. NTM Research
LINE: Vaccines Around the City
Dr Cristian Alfredo Segura-Cerda, Centro de Investigación y Asistencia en Tecnología y Diseño de Jalisco (CIATEJ) & Secretariat of Science, Humanities, Technology and Innovation (SECIHTI), Mexico
Lionex Diagnostics & Therapeutics GmbH
Germany
Lisa Stockdale 2019
Liverpool School of Tropical Medicine
United Kingdom
LMIC Publication Fund
Lok Bahadur Shrestha 2019
Lomonosov Moscow State University
Russia
London ECR Symposium
9 June 2025, 9:00am to 9:00am
This free one-day symposium is a celebration of ECR-led infection research and open to all scientists from students to principle investigators.
London School of Hygiene and Tropical Medicine
United Kingdom
Luciana Balboa Poster 2023
Luciana Balboa Poster 2024
Ludoviko Zirimenya Poster 2023
Lydia Mosi Poster 2024
M. ulcerans challenge agent clinical-grade manufacture
Dr Stephen Muhi, University of Melbourne & Royal Melbourne Hospital, Australia